In the five years to 2016, the Antiseptic Manufacturing industry steadily expanded due to improved demand from household consumers and the food and healthcare sectors. Increased demand for healthcare from the aging population and expanded insurance coverage under the Affordable Care Act boosted purchases of industry products by healthcare facilities, driving revenue growth from the industry's largest market. However, profit has been tempered by heightened FDA regulations requiring manufacturers to assure the safety and efficacy of their products. Over the next five years, favorable economic and demographic trends will continue to drive revenue, and exports to emerging economies will further bolster growth.
This industry manufactures antiseptic ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.